ICYMI: Among pts receiving therapy for #heartfailure, those who also received empagliflozin had a lower risk of CV death or hospitalization for HF, per findings from the EMPEROR-Reduced trial presented at #ESCCongress & simultaneously published in @NEJM: https://t.co/i95wBIMqku
more on PTT in COVID
- PTT can be artificially hi 2/2 lupus anticoag
- PTT can be dragged down by high VIII & fibrinogen (causing apparent heparin resistance)
- when possible, titrate heparin gtts against anti-Xa, not PTT (probably better regardless)
https://t.co/lobpwSVN1I